文献速递垂体与肾上腺疾病糖尿病甲状腺疾病

法国APECED队列前瞻性纵向随访的启示

Lessons From Prospective Longitudinal Follow-up of a French APECED Cohort.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

这项法国多中心前瞻性观察研究纳入25例APECED患者,鉴定出11种AIRE基因变异(含2种新变异),最常见为芬兰变异c.769C>T;19/25例有经典三联征,系统性筛查发现更多潜在致死性非内分泌表现;15/19例有自然杀伤细胞减少伴T、B淋巴细胞稳态年龄依赖性改变(P<.001),所有受检血清抗干扰素-α阳性。

要点

  • APECED患者AIRE基因变异谱高度多样,本队列发现2种未报道变异。
  • 系统性筛查可发现更多潜在致死性非内分泌表现。
  • 自然杀伤细胞减少及B细胞稳态年龄依赖性改变与疾病严重程度相关。

核心结论

  • 本首个前瞻性队列显示AIRE基因型高度变异,发现2种新基因变异;系统性筛查下潜在致死性非内分泌表现患病率更高,这些表现与年龄依赖性B细胞减少可能共同导致疾病严重程度。
  • 作者认为对所有综合征表现进行系统性筛查可助早期诊断,支持疫苗接种和靶向治疗策略。

研究设计与样本

  • 法国全国性、多中心前瞻性观察研究(NCT03751683),收集遗传、临床、生物学和免疫学数据。
  • 共纳入25例患者(来自23个家庭)。

主要发现

  • 鉴定出11种不同AIRE变异,其中2种为新变异:内含子变异c.653-70G>A和c.1066del(p.Arg356GlyfsX22)(外显子9)。
  • 最常见变异为芬兰变异c.769C>T(16个等位基因),其次为c.967_979del13(15个等位基因),后者似乎与较轻表型相关。
  • 25例中17例为纯合子;临床表现为中位数7种;19/25例出现甲状旁腺功能减退-肾上腺功能不全-CMC三联征,8/13例有肺部受累,20/25例有外胚层营养不良,8/25例有吸收不良,6/23例有无脾。
  • 19例中15例有自然杀伤细胞减少,伴CD4+和CD8+ T淋巴细胞增加及年龄依赖性B淋巴细胞稳态改变,与匹配对照相比P<.001,且与疾病严重程度相关。
  • 所有检测血清(n=18)抗干扰素-α阳性,15/18抗IL-22抗体阳性,13/18抗IL-17F抗体阳性,除与CMC相关外无明确表型相关性。

临床怎么用

  • 作者认为对所有综合征表现进行系统性筛查可助早期诊断,支持疫苗接种和靶向治疗策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome is a rare disease caused by biallelic mutations of the AIRE gene, usually presenting with the triad hypoparathyroidism-adrenal failure-chronic mucocutaneous candidiasis (CMC) and nonendocrine manifestations. The aim of this study was to determine the molecular profile of the AIRE gene, the prevalence of rare manifestations, and to characterize immunological disturbances in a French cohort. PATIENTS AND METHODS: A national, multicenter prospective observational study to collect genetic, clinical, biological, and immunological data (NCT03751683). RESULTS: Twenty-five patients (23 families) were enrolled. Eleven distinct AIRE variants were identified, 2 of which were not previously reported: an intronic variant, c.653-70G > A, and a c.1066del (p.Arg356GlyfsX22) variant (exon 9). The most common was the Finnish variant c.769C > T (16 alleles), followed by the variant c.967_979del13 (15 alleles), which seemed associated with a less severe phenotype. Seventeen out of 25 patients were homozygote. The median number of clinical manifestations was 7; 19/25 patients presented with the hypoparathyroidism-adrenal failure-CMC triad, 8/13 showed pulmonary involvement, 20/25 had ectodermal dystrophy, 8/25 had malabsorption, and 6/23 had asplenia. Fifteen out of 19 patients had natural killer cell lymphopenia with an increase in CD4+ and CD8+ T lymphocytes and an age-dependent alteration of B lymphocyte homeostasis compared with matched controls (P < .001), related to the severity of the disease. All tested sera (n = 18) were positive for anti-interferon-α, 15/18 for anti-IL-22 antibodies, and 13/18 for anti-IL-17F antibodies, without clear phenotypic correlation other than with CMC. CONCLUSION: This first prospective cohort showed a high AIRE genotype variability, with 2 new gene variants. The prevalence of potentially life-threatening nonendocrine manifestations was higher with systematic screening. These manifestations could, along with age-dependent B-cell lymphopenia, contribute to disease severity. Systematic screening for all the manifestations of the syndrome would allow earlier diagnosis, supporting vaccination and targeted therapeutic approaches.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Humbert L, Proust-Lemoine E, Dubucquoi S, et al. Lessons From Prospective Longitudinal Follow-up of a French APECED Cohort. J Clin Endocrinol Metab. 2025. PMID: 38605470. doi:10.1210/clinem/dgae211

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。